Yoel Romero has been granted another interim title shot, but the Ultimate Fighting Championship middleweight has another kind of fight in the works, too.
According to a report by Forbes, Romero has filed a lawsuit against Goldstar Performance Products in New Jersey Superior Court. The suit regards Romero’s 2015 positive test for Ibutamoren. The U.S. Anti-Doping Agency describes Ibutamoren as “a prohibited substance in the class of Peptide Hormones, Growth Factors, Related Substances and Mimetics under the UFC Anti-Doping Policy.”
The suit alleges that Goldstar “failed to maintain the production facility” and “knew” that it was producing supplements contaminated with unlisted substances.